## Biography

> _“I hope that we help manage more serious diseases that are currently handled only with drugs.”_

Since launch in October 2018, Dr. Li has led Filtricine from cell-based technology to clinical trial initiation. He and the cofounders incubated the company at IndieBio and secured seed financing led by True Ventures and SOSV. As an expert in cancer metabolism, Dr. Li discovered and patented Targeted Nutrients Deprivation while at Stanford University Medical School. That patent was followed by two additional Filtricine patents. Dr. Li holds a PhD from the University of Maryland and trained with Dr. Mike Snyder at Yale and Stanford Universities.

## Our Team

###### Dr. Grace Xiaolu Yang

COO, VP of Research & Co-founder

###### Mike Partsuf

Senior Food Scientist

###### Emily Sinovic

Public Relations Consultant

###### Todd Lorenz

Clinical Development Consultant

## Our Advisors

###### Dr. Mike P Snyder

Stanford University School of Medicine

###### Peter B Hutt

Senior Counsel at Covington & Burling LLP

###### Brad Barnes

Culinary Institute of America

###### Dr. Dariush Mozaffarian

Tufts University

###### Dr. Yung-Chi Cheng

Yale University School of Medicine

###### Dr. Danhua Xiao

Atlantic Health Metabolic Center

###### Dr. Joseph V Rodricks

Ramboll (formerly ENVIRON)

###### Alister Thomson

Bristol Myers Squibb (Former)

###### Jeff Depew

Sand Hill Angels

###### Dr. Wei Jiang

Medical Affairs at MorphoSys

## Our Board of Directors

###### Dr. Xiyan Li

Co-founder

###### Dr. Rami El Assal

Founding Partner at Boutique Venture Partners

###### Drew Lanza

Founding Partner at Berkeley Catalyst Fund

We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.